Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square
Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its ...
Biogen Inc. stock underperforms Wednesday when compared to competitors
Shares of Biogen Inc. BIIB shed 1.16% to $141.43 Wednesday, on what proved to be an all-around great trading session for the ...
Nasdaq19d
What the Options Market Tells Us About Biogen
High-rolling investors have positioned themselves bullish on Biogen (NASDAQ:BIIB), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...
Business Insider24d
Biogen, Eisai confirm CHMP positive opinion for lecanemab
Eisai (ESAIY) and Biogen (BIIB) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti ...
CBSSports.com27d
Agent's Take: Bengals could pay a much steeper price if they don't heed Joe Burrow's plea to lock up stars
Pro Bowl quarterback Joe Burrow has made it crystal clear how he wants the Cincinnati Bengals to approach this offseason. Do whatever it takes to ensure that wide receiver Ja'Marr Chase, edge ...
Nasdaq27d
Biogen Stock Outlook: Is Wall Street Bullish or Bearish?
Biogen Inc. (BIIB), based in Cambridge, Massachusetts, is a leading biotechnology company focused on developing and delivering innovative therapies for neurological and neurodegenerative diseases ...
Yahoo Finance28d
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
A cost-saving effort by NHS England to transition multiple sclerosis (MS) patients from Biogen Inc’s (NASDAQ:BIIB) Tysabri (natalizumab) to the biosimilar drug Tyruko has led to significant side ...